Newcleo Lands on Nasdaq With $247M for U.S. Growth
The European nuclear technology company has begun Nasdaq trading after raising $247 million, with part of the capital earmarked for U.S. reactors and fuel production.
European advanced nuclear company newcleo has begun trading on Nasdaq after completing its business combination with NewHold Investment Corp III and raising approximately $247 million in gross proceeds.
The company's ordinary shares began trading under the ticker NWCL on September 22, giving newcleo access to U.S. public capital as it develops advanced modular reactors and recycled nuclear-fuel technology.
newcleo says the proceeds will support growth in both the United States and Europe, including regulatory work, reactor development and potential fuel-manufacturing projects.
A $247 million step into U.S. capital markets
The transaction delivered approximately $247 million in gross proceeds.
That includes a $216 million private investment in public equity and $31 million from NewHold's trust account at closing.
An additional $75 million could become available through a previously disclosed forward-purchase agreement.
The transaction valued newcleo at an approximately $2.4 billion pre-money equity value.
Including the latest transaction and other capital raised since the combination was announced, newcleo says it has now raised more than $1 billion.
Why America matters to newcleo
newcleo's Nasdaq listing is not only about accessing American investors.
The company is actively exploring opportunities to deploy both reactors and nuclear-fuel manufacturing capacity in the United States.
It is also working with U.S. nuclear regulators and expects formal licensing activity to become more important as sites are selected.
The company has said the Savannah River complex in South Carolina is among the locations being considered for a first U.S. reactor and fuel-production operation.
newcleo has indicated that its current ambition is to produce its first U.S. fuel by the end of 2031 and begin reactor operations in the country around the end of 2032, although those timelines remain dependent on licensing, site selection and execution.
The technology behind the expansion
newcleo is developing lead-cooled fast reactors and mixed-oxide nuclear fuel made using recycled nuclear materials.
Its strategy is built around combining advanced reactor designs with fuel recycling, with the aim of reducing dependence on newly mined uranium while making greater use of existing nuclear materials.
The company says it employs more than 900 people across Europe and the United States and has built more than 100 industrial partnerships.
Its European operations remain central to the business, with research, engineering, manufacturing and regulatory activity spread across countries including France, Italy and the United Kingdom.
Keeping Europe while raising in America
newcleo has been explicit that a U.S. listing does not mean moving its European core to America.
In documents connected to the Nasdaq transaction, the company said it intends to keep its headquarters, core operations, research and development, manufacturing footprint and strategic decision-making in Europe.
That creates a transatlantic model in which European technology and industrial capacity are paired with deeper access to U.S. capital markets and potential American deployment opportunities.
Why Nasdaq
Founder and CEO Stefano Buono has described the U.S. market as particularly attractive because of the depth of capital available for high-growth and technically complex businesses.
For a capital-intensive nuclear company, that matters more than it would for many software businesses.
Developing reactors, fuel facilities and manufacturing infrastructure requires large amounts of long-term financing well before projects begin generating commercial returns.
What this means for European companies
newcleo illustrates how access to America can become part of a European company's financing strategy even when the business intends to keep its operational center in Europe.
The company is using U.S. public markets to finance a transatlantic growth plan rather than treating America as a replacement for its European base.
For capital-intensive European companies, that distinction is important.
Scaling in America can mean building reactors, factories or sales operations in the country, but it can also mean using American capital markets to finance projects on both sides of the Atlantic.